Ondine Continues Commercial Growth
Ondine Biomedical Inc. (LON:OBI), the Canadian life sciences company pioneering light-activated antimicrobial treatments, announces that it has made significant progress with the commercial roll-out of its novel nasal decolonization technology, Steriwave®, in both Canada and the UK. Steriwave is a simple 5-minute procedure that reduces healthcare-associated infections (HAIs) by rapidly decolonizing the nose without the use of antibiotics or...
Read more








